Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-18.8%/yr
Quarterly compound
Percentile
P84
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 28.50% |
| Q3 2025 | 15.25% |
| Q2 2025 | -7.39% |
| Q1 2025 | 20.09% |
| Q4 2024 | 15.38% |
| Q3 2024 | -8.33% |
| Q2 2024 | -9.09% |
| Q1 2024 | -39.95% |
| Q4 2023 | -1.42% |
| Q3 2023 | -7.04% |
| Q2 2023 | -11.56% |
| Q1 2023 | -15.69% |
| Q4 2022 | 53.25% |
| Q3 2022 | 14.29% |
| Q2 2022 | 41.67% |
| Q1 2022 | 38.46% |
| Q4 2021 | -14.71% |
| Q3 2021 | 30.61% |
| Q2 2021 | -13.95% |
| Q1 2021 | 15.69% |
| Q4 2020 | -24.39% |
| Q3 2020 | 0.00% |
| Q2 2020 | 14.58% |
| Q1 2020 | -29.73% |
| Q4 2019 | 9.76% |
| Q3 2019 | 0.00% |
| Q2 2019 | -51.85% |
| Q1 2019 | 20.59% |
| Q4 2018 | 46.03% |
| Q3 2018 | -16.67% |
| Q2 2018 | -20.00% |
| Q1 2018 | -60.71% |
| Q4 2017 | 0.00% |